Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies
Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies
Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
All Stories

Technology

1337 articles · sorted by newest first

AllAI & SocietyBig Tech & MarketsScience & SpaceCyber & Privacy

Latest in Technology

Latest in Technology
20 results
Technology 5/23/2026

How Justin Jadali Bridges Mechanical Engineering and Bioengineering Research

Emerging research spearheaded by Justin Jadali Bridges is spotlighting the critical convergence of Mechanical Engineering and Bioengineering, a synergy increasingly vital for tackling complex challenges within modern Biomedical Engineering. As highlighted by Diario Palm Beach, Bridges' work underscores how these traditionally distinct academic disciplines are now inextricably linked, driving innovation in areas ranging from advanced prosthetics to novel drug delivery systems. This integration reflects a broader academic and industrial shift towards holistic problem-solving in healthcare technology.

Editorial Team1 min
How Justin Jadali Bridges Mechanical Engineering and Bioengineering Research
Technology 5/23/2026

Advancing Scientific Innovation Through Peptide Research Chemicals

The field of peptide research chemicals is experiencing a significant boom, fueled by a 'peptide renaissance' marked by a surge in both scientific breakthroughs and substantial investment. This renewed focus, particularly within biotechnology and pharmaceutical sciences, is driven by advanced synthesis techniques, enhanced understanding of biological mechanisms, and groundbreaking clinical successes, most notably with GLP-1 Agonists for metabolic diseases. Researchers are actively expanding the Drug Discovery Pipeline, leveraging peptides for their high specificity and lower toxicity profiles, targeting a broad spectrum of conditions from Oncology and autoimmune disorders to infectious diseases and neurodegenerative conditions. The integration of AI in Drug Discovery is further accelerating the identification and optimization of novel peptide candidates, positioning this sector at the forefront of modern biomedical innovation.

Editorial Team1 min
Advancing Scientific Innovation Through Peptide Research Chemicals
Technology 5/23/2026

A PDF let the internet hear the final words in the cockpit of a UPS plane as it crashed. The NTSB now wants it taken down

A cutting-edge application of digital forensics has unearthed audio from the cockpit of UPS Flight 1354, which crashed in Birmingham, Alabama, on August 14, 2013. This unprecedented event saw the final, harrowing moments of the flight extracted from what was previously considered a static PDF document by leveraging advanced audio extraction technology, likely involving sophisticated spectrogram analysis. In response, the National Transportation Safety Board (NTSB) has taken the extraordinary step of demanding its removal from public platforms, citing profound concerns over victim privacy, the integrity of ongoing and future accident investigations, and the potential for misuse of such highly sensitive data.

Editorial Team1 min
A PDF let the internet hear the final words in the cockpit of a UPS plane as it crashed. The NTSB now wants it taken down
Technology 5/23/2026

I went to one of Wall Street's biggest tech conferences. The plumbing behind AI dominated the conversation.

At a major Wall Street tech conference, the discourse overwhelmingly centered on the foundational "plumbing" behind Artificial Intelligence rather than the highly anticipated trio of potentially massive Initial Public Offerings. Investment bankers, venture capitalists, and tech executives converged on discussions about the physical and digital infrastructure essential for scaling the current AI boom, marking a significant recalibration of market focus from front-end applications to the compute-intensive back-end.

Editorial Team1 min
I went to one of Wall Street's biggest tech conferences. The plumbing behind AI dominated the conversation.
Technology 5/23/2026

Will Kevin O’Leary’s massive Utah data center actually get built? Don’t count on it, says this energy analyst

Shark Tank investor Kevin O'Leary's audacious "Stratos Project," also known as Wonder Valley, a proposed 9-gigawatt (GW) data center in Utah spanning 40,000 acres, is facing intense skepticism regarding its feasibility. Olivia Wang, a research analyst at Sightline Climate, an energy transition intelligence firm, assigns the project a mere 15% likelihood of materialization, citing a conspicuous absence of fundamental "building blocks." Critical components such as secured financing, definitive power contracts, confirmed tenant agreements, and essential environmental permits—particularly an air permit—remain unaddressed, directly contradicting optimistic construction timelines from O'Leary Digital and its joint venture partner, West GenCo. The sheer scale of the project, poised to consume more than double Utah's average electricity use and operate entirely off-grid, is unprecedented and currently lacks any operational precedent within the industry.

Editorial Team1 min
Will Kevin O’Leary’s massive Utah data center actually get built? Don’t count on it, says this energy analyst
Technology 5/23/2026

Quantum sensors beat hyped computers to the real world by measuring invisible fields

Quantum sensors are rapidly achieving real-world deployment, demonstrating superior precision in measuring elusive phenomena, effectively outpacing the more hyped, general-purpose quantum computers in practical application. Leveraging fundamental principles of quantum mechanics like superposition and entanglement, these sensors can detect and measure previously invisible fields, such as minuscule magnetic fields generated by brain activity or subtle gravitational anomalies, with unprecedented sensitivity.

Editorial Team1 min
Quantum sensors beat hyped computers to the real world by measuring invisible fields
Technology 5/23/2026

Dell Technologies Stock Hits 52-Week High - Here's Why

Dell Technologies Inc. (NYSE: DELL) recently soared to a new 52-week high, driven by bullish Wall Street analyst price forecast revisions ahead of its fiscal first-quarter 2027 earnings report, slated for May 28. The surge reflects robust market confidence in Dell's intensified AI infrastructure strategy, unveiled at Dell Technologies World 2024, which featured significant product launches like advanced PowerEdge AI servers and expanded partnerships with key players such as NVIDIA. This upward trajectory was further amplified by strong quarterly results from rival Lenovo, which also signaled robust demand within the AI-driven enterprise hardware sector, validating Dell's strategic focus.

Editorial Team1 min
Dell Technologies Stock Hits 52-Week High - Here's Why
Technology 5/22/2026

She Built AI Tool That Replaced Her: Man’s Claim On Meta Layoff Goes Viral

Tech giant Meta is currently undergoing significant restructuring, marked by thousands of job cuts, including a reported 8,000 in the latest wave. This follows an internal memo from Meta’s Head of People, emphasizing a pivot towards "flatter teams" and "smaller, AI-focused groups." For months, employees have reportedly been pushed deeper into AI initiatives, with constant reshuffling and managerial discussions centered on speed, leaner structures, and an "AI-first strategy." Amidst this overhaul, a LinkedIn post went viral claiming that an employee was laid off after building an AI tool that subsequently replaced her role, a potent anecdote symbolizing the complex human-machine interaction at the heart of the company's aggressive technological shift.

Editorial Team1 min
She Built AI Tool That Replaced Her: Man’s Claim On Meta Layoff Goes Viral
Technology 5/22/2026

Belgium: Full-Life Technologies raises US$150m to advance clinical stage assets

Full-Life Technologies, a cutting-edge radiotherapeutics company with significant operational hubs spanning Belgium, Germany, and China, has successfully secured a monumental US$150 million in a Series B financing round. This substantial capital infusion, led by the prominent healthcare investment firm Vivo Capital, is strategically earmarked to aggressively advance the company's robust pipeline of clinical stage assets. Full-Life specializes in the innovative development of radiopharmaceuticals, which are designed to deliver highly targeted radiation for the precise treatment of various oncology indications, marking a significant stride in the burgeoning field of precision medicine.

Editorial Team1 min
Belgium: Full-Life Technologies raises US$150m to advance clinical stage assets
Technology 5/22/2026

Fushi Tech Launches General-Purpose AI Agent for Overseas Merchants

Fushi Tech, a Singapore-based subsidiary of the prominent Hong Kong-listed fintech entity Yeahka (9923.HK), has unveiled Fynix AI Shop, an advanced general-purpose AI agent engineered specifically for overseas merchants. This strategic upgrade positions Fynix AI Shop as an autonomous digital employee, designed to seamlessly manage the entire customer lifecycle – from initial acquisition and conversion to payment processing and fostering repeat purchases. By embedding directly into a merchant's existing CRM system, the AI recognizes returning customers, provides instant personalized responses to inquiries via messaging apps, offers tailored product recommendations, and guides users through the sales funnel all the way to order completion. This move signifies a shift from conventional marketing tools to intelligent, self-executing business agents.

Editorial Team1 min
Fushi Tech Launches General-Purpose AI Agent for Overseas Merchants
Technology 5/22/2026

Scientists propose hemp-based biorefinery to produce green hydrogen, bioenergy and therapeutic cannabinoids

Scientists have unveiled a groundbreaking concept for an integrated hemp-based biorefinery designed to revolutionize the production of clean energy and high-value pharmaceuticals. This proposed model aims to process industrial hemp into green hydrogen, diverse bioenergy products like biofuels or electricity, and therapeutic cannabinoids—all from a single cultivation cycle. The core innovation lies in its "zero-waste" philosophy, ensuring every part of the crop is efficiently utilized, from lignocellulosic biomass for energy conversion via thermochemical or biochemical processes, to targeted extraction of specific compounds for medical applications. This holistic approach signals a significant step towards maximizing the economic and environmental utility of a rapidly re-emerging agricultural commodity.

Editorial Team1 min
Scientists propose hemp-based biorefinery to produce green hydrogen, bioenergy and therapeutic cannabinoids
Technology 5/22/2026

Cycling may significantly improve brain health and well-being

A recent peer-reviewed publication in *Frontiers in Sports and Active Living* has confirmed that cycling acts as a powerful, accessible intervention for significantly improving brain health and overall well-being. The study elaborates on the physiological mechanisms by which regular bicycling enhances cognitive function, bolstering aspects like working memory, executive control, and attentional focus. Key findings point to increased cerebral blood flow, enhanced neurogenesis in brain regions like the hippocampus, and boosted neuroplasticity, which collectively contribute to improved cognitive resilience and a reduced risk profile for neurodegenerative diseases. This research effectively consolidates existing evidence, providing a robust scientific underpinning for integrating cycling into public health strategies aimed at ameliorating cognitive decline and promoting mental health across diverse age demographics.

Editorial Team1 min
Cycling may significantly improve brain health and well-being
Technology 5/22/2026

Oral drug improves platelet recovery during chemotherapy in gastrointestinal cancer patients

Researchers from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and Mass General Hospital have announced promising results from a Phase 2 clinical trial. The study focused on Eltrombopag, an oral Thrombopoietin Receptor Agonist (TPO-RA) already approved for conditions like chronic idiopathic thrombocytopenia. In this new trial, Eltrombopag significantly improved platelet recovery and helped gastrointestinal cancer patients maintain adequate platelet counts, crucial for continuing scheduled chemotherapy without dose reductions or delays. This breakthrough addresses a critical challenge in oncology, where chemotherapy-induced myelosuppression often disrupts treatment protocols, impacting patient outcomes.

Editorial Team1 min
Oral drug improves platelet recovery during chemotherapy in gastrointestinal cancer patients
Technology 5/22/2026

Experimental virus therapy targets resistant high-grade neuroendocrine tumors

A groundbreaking Phase I clinical trial is underway, investigating an experimental oncolytic virus therapy designed to enhance immunotherapy effectiveness against resistant high-grade neuroendocrine tumors (NETs). This early-stage study aims to assess the safety and preliminary efficacy of using a genetically modified virus that selectively targets and lyses cancer cells, simultaneously stimulating an anti-tumor immune response. The trial focuses on patients with aggressive NETs, a notoriously difficult-to-treat cancer sub-type often characterized by high proliferation rates and limited response to conventional systemic therapies, including existing immunotherapies. This represents a critical pivot in oncology, moving towards novel combinatorial approaches to overcome entrenched treatment resistance.

Editorial Team1 min
Experimental virus therapy targets resistant high-grade neuroendocrine tumors
Technology 5/22/2026

Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting

Formosa Pharmaceuticals has announced that its abstract highlighting the differentiated binding profile and preclinical efficacy of TSY-310, a novel bispecific antibody-drug conjugate (ADC), has been selected for presentation at the prestigious 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. This upcoming presentation signifies a crucial milestone for the Taiwan-based biopharmaceutical firm, positioning TSY-310 as a promising candidate in the intensely competitive oncology drug development landscape and garnering attention within the global scientific community.

Editorial Team1 min
Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting
Technology 5/22/2026

Study finds nearly 147,000 AI-generated fake citations in scientific papers across major research databases

A groundbreaking study has exposed nearly 147,000 AI-generated fake citations embedded within scientific papers across leading academic databases. This unprecedented surge in erroneous references is attributed to researchers misusing large language model (LLM) based AI chatbots, failing to verify the legitimacy of generated references before inclusion. Concurrently, arXiv, a pivotal open-access preprint server, has formally announced a ban on submissions containing such 'hallucinated citations,' signaling a critical pivot in safeguarding academic integrity.

Editorial Team1 min
Study finds nearly 147,000 AI-generated fake citations in scientific papers across major research databases
Technology 5/22/2026

Canadian regulator triples US streamers' financial contributions to Canadian content

The Canadian Radio-television and Telecommunications Commission (CRTC) has implemented a landmark policy, requiring major international streaming services like Netflix, Disney+, and Amazon Prime Video to allocate 15% of their Canadian gross revenues towards the creation and promotion of Canadian content (CanCon). This directive, effective September 2024 and enabled by the Online Streaming Act (Bill C-11), represents an unprecedented regulatory burden on these digital platforms, which previously operated largely outside such financial obligations. While not a literal tripling of a pre-existing mandated streamer contribution, the move dramatically increases their financial commitment from what was previously negligible or voluntary, aiming to inject hundreds of millions annually into Canada's domestic media ecosystem.

Editorial Team1 min
Canadian regulator triples US streamers' financial contributions to Canadian content
Technology 5/22/2026

Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors

Aktis Oncology (NASDAQ: AKTS) just dropped promising "first-in-human" data for their experimental cancer treatment, AKY-2519. This novel "miniprotein radioconjugate," engineered to precisely target "B7-H3 expressing tumors," demonstrated "robust tumor uptake"—meaning it's effectively hitting its intended target—while concurrently achieving "limited normal tissue exposures." Essentially, this groundbreaking approach is designed to deliver therapeutic radiation with high precision, minimizing collateral damage to healthy cells. These findings, derived from early "clinical imaging and dosimetry data" in patients with "mCRPC (Metastatic Castration-Resistant Prostate Cancer)" and other solid tumor types, are slated for prominent presentation at the highly anticipated 2026 ASCO Annual Meeting.

Editorial Team1 min
Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors
Technology 5/22/2026

Macrocyclic host molecules observed working together on a surface

A joint research team from Japan's Kanazawa University and Kyoto University has achieved a significant breakthrough, directly visualizing how densely assembled "macrocyclic host molecules" collaboratively capture "guest molecules" on a surface. Utilizing advanced "Atomic Force Microscopy (AFM)" techniques, the researchers successfully tracked both the formation of "host-guest complexes" and their reversible association-dissociation dynamics at the single-molecule level. This direct observation provides unprecedented insight into the intricate mechanisms of molecular recognition and self-assembly, laying foundational knowledge for future nanoscale engineering.

Editorial Team1 min
Macrocyclic host molecules observed working together on a surface
Technology 5/22/2026

OpenAI's Top-Safety Expert Departs Company: 'Not An Easy Decision'

Computer scientist Aleksander Madry, a key figure in OpenAI's safety initiatives, has announced his departure from the ChatGPT parent company after nearly three years. Madry, who initially joined OpenAI in 2021 and served as the head of its Preparedness team, focused on safeguarding against "catastrophic risks related to frontier AI models." He was later reassigned to a role concentrating on AI reasoning. His exit adds to a series of high-profile departures from OpenAI’s safety-centric divisions, most notably following the May 2024 resignations of co-founder Ilya Sutskever and Jan Leike from the Superalignment team, which was specifically tasked with controlling future superintelligent AI.

Editorial Team1 min
OpenAI's Top-Safety Expert Departs Company: 'Not An Easy Decision'
‹ Prev1…6061626364…67Next ›

Page 62 of 67 · 1337 articles

ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies